We are live on ! Find out more
SBBP

Strongbridge Biopharma plc.
SBBP

Delisted

SBBP was delisted on the 5th of October, 2021.

Back to rankings

15 hedge funds and large institutions have $41.8M invested in Strongbridge Biopharma plc. in 2016 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

28% more capital invested

Capital invested by funds: $32.6M → $41.8M (+$9.27M)

7% more funds holding

Funds holding: 14 → 15 (+1)

67% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 6

Holders
15
Holders Change
+1
Holders Change %
+7.14%
% of All Funds
0.4%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
2
Increased
2
Reduced
6
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
+$45K
2
TRCT
Tower Research Capital (TRC)
New York
+$3.38K
3
WP
WealthPLAN Partners
Nebraska
+$3.34K
4
GPCM
Granite Point Capital Management
Massachusetts
+$5

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$783K
2
Bank of America
Bank of America
North Carolina
-$12K
3
UBS Group
UBS Group
Switzerland
-$5.98K
4
CC
Caxton Corporation
New Jersey
-$3.3K
5
BA
BlackRock Advisors
Delaware
-$2.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$13.1M -$783K -173,671 -6%
NMC
2
NEA Management Company
Maryland
$11.2M – – –
BC
3
Broadfin Capital
New York
$8.65M – – –
TAF
4
Tredje AP-fonden
Sweden
$4.75M – – –
GPCM
5
Granite Point Capital Management
Massachusetts
$3.68M +$5 +1 +0%
CC
6
Caxton Corporation
New Jersey
$184K -$3.3K -732 -2%
BA
7
BlackRock Advisors
Delaware
$167K -$2.7K -599 -2%
BFA
8
BlackRock Fund Advisors
California
$137K +$45K +9,978 +62%
BIM
9
BlackRock Investment Management
Delaware
$10K – – –
BJ
10
BlackRock Japan
Japan
$9K -$600 -133 -7%
Manulife (Manufacturers Life Insurance)
11
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$5K – – –
UBS Group
12
UBS Group
Switzerland
$4K -$5.98K -1,326 -64%
TRCT
13
Tower Research Capital (TRC)
New York
$4K +$3.38K +749 New
WP
14
WealthPLAN Partners
Nebraska
$3.71K +$3.34K +740 New
Acadian Asset Management
15
Acadian Asset Management
Massachusetts
$2K -$920 -204 -36%
Bank of America
16
Bank of America
North Carolina
– -$12K -3,114 Closed

SBBP Hedge Fund Activity: Q3 2016 in Review

15 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Strongbridge Biopharma plc. (SBBP) for Q3 2016, worth a combined $41.8M — up 28% from $32.6M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new SBBP positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 6 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $45K. The largest seller was RA Capital Management, cutting an estimated $783K.

  • 15 institutional investors held Strongbridge Biopharma plc. (SBBP) as of Q3 2016, up from 14 in Q2 2016.
  • Funds reported $41.8M of Strongbridge Biopharma plc. stock for Q3 2016, up 28% quarter-over-quarter.
  • 2 funds opened new Strongbridge Biopharma plc. positions in Q3 2016 and 1 closed out, a net change of +1 holder.
  • The largest Strongbridge Biopharma plc. buyer in Q3 2016 was BlackRock Fund Advisors, an estimated $45K added.
  • The largest Strongbridge Biopharma plc. seller in Q3 2016 was RA Capital Management, an estimated $783K sold.

Based on aggregated 13F filings for Q3 2016.